PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsHaloperidol decanoate
Haloperidol decanoate
Haldol, Haloperidol (haloperidol decanoate) is a small molecule pharmaceutical. Haloperidol decanoate was first approved as Haldol on 1982-01-01. It is used to treat child behavior disorders, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders, and substance withdrawal syndrome amongst others in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A, D(4) dopamine receptor, D(3) dopamine receptor, and D(2) dopamine receptor. In addition, it is known to target 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 7, histamine H1 receptor, D(1A) dopamine receptor, 5-hydroxytryptamine receptor 1D, D(1B) dopamine receptor, voltage-gated delayed rectifier potassium channel KCNH1; potassium voltage-gated channel subfamily H member 1, and G protein-activated inward rectifier potassium channel 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
hereditary congenital and neonatal diseases and abnormalitiesD009358
signs and symptoms pathological conditionsD013568
chemically-induced disordersD064419
mental disordersD001523
Trade Name
FDA
EMA
Haldol, Haloperidol decanoate (discontinued: Haloperidol decanoate)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Haloperidol decanoate
Tradename
Company
Number
Date
Products
HALDOLJohnson & JohnsonN-018701 RX1986-01-14
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
haldol decanoateNew Drug Application2025-01-30
haloperidol decanoateANDA2025-09-30
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
substance withdrawal syndromeEFO_0005800D013375—
vomiting—D014839R11.1
tourette syndromeEFO_0004895D005879F95.2
schizophreniaEFO_0000692D012559F20
psychotic disorders—D011618F20.81
schizophrenia spectrum and other psychotic disorders—D019967—
child behavior disorders—D002653—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N05: Psycholeptics
— N05A: Antipsychotics
— N05AD: Butyrophenone derivatives, antipsychotics
— N05AD01: Haloperidol
HCPCS
Code
Description
J1631
Injection, haloperidol decanoate, per 50 mg
Clinical
Clinical Trials
193 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Psychomotor agitationD011595——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHaloperidol decanoate
INNhaloperidol
Description
Haloperidol decanoate is an organic molecular entity.
Classification
Small molecule
Drug classantipsychotics (haloperidol type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
Identifiers
PDB—
CAS-ID74050-97-8
RxCUI—
ChEMBL IDCHEMBL1200986
ChEBI ID—
PubChem CID52919
DrugBankDBSALT001195
UNII IDJ6292F8L3D (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
KCNH1
KCNH1
Organism
Homo sapiens
Gene name
KCNH1
Gene synonyms
EAG, EAG1
NCBI Gene ID
3756
Protein name
potassium voltage-gated channel subfamily H member 1
Protein synonyms
EAG channel 1, ether-a-go-go 1, Ether-a-go-go potassium channel 1, ether-a-go-go, Drosophila, homolog of, h-eag, hEAG1, potassium channel, voltage gated eag related subfamily H, member 1, potassium voltage-gated channel, subfamily H (eag-related), member 1, Voltage-gated potassium channel subunit Kv10.1
Uniprot ID
Q14CL3
Mouse ortholog
Kcnh1 (16510)
potassium voltage-gated channel subfamily H member 1 (Q60603)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 696 documents
View more details
Safety
Black-box Warning
Black-box warning for: Haldol decanoate, Haloperidol decanoate
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,773 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use